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Abstract 
Castleman’s disease is a rare entity with an
unknown etiology which was first described by
Castleman in 1954. It is a lymphoproliferative
disorder  histologically  classified  into  three
types;  hyaline-vascular,  plasma  cell  type  and
mixed type. It might be localized or multicen-
tric and usually involves the mediastinum. We
report a case of Castleman’s disease discov-
ered accidentally in a case of blunt chest trau-
ma  which  caused  a  challenging  diagnostic
process and management. 
Case Report
A 39-year old man presented to the ER with
progressive dyspnea and cough for the last six
months. He had history of blunt chest trauma
eight months ago with right sided fractured
ribs and right sided hemothorax that was treat-
ed with tube thoracostomy. He was seen by the
ER physicians and was found to have a marked
decrease in air entry and dullness on percus-
sion on the left hemithorax. Laboratory inves-
tigations showed normal blood count and full
biochemical  screen;  no  anemia,  hypoalbu-
minemia, or hypergammaglubinemia. CRP and
ESR were normal.
A  chest  radiograph  revealed  old  fractured
ribs on the right side, obliteration of the right
costophrenic angle, and near total opacity of
the left hemithorax, with evidence of an under-
lying mass (Figure 1).
Trial aspiration of the left side of the chest
was  positive  and  drained  hemorrhagic  effu-
sion. A left-sided chest tube was inserted and
drained  more  than  2000cc  of  hemorrhagic
effusion  with  normal  analysis,  cytology  and
negative  culture.  A  follow-up  CXR  showed  a
persistent opacity of the left hemithorax and
CT chest with contrast was performed. The CT
revealed collapsed left lower lung lobe, multi-
ple  variable  size  mediastinal  lymph  node
enlargement,  and  a  well  defined  heteroge-
neously  enhancing  mass  in  left  para-aortic
area  extending  to  the  aorto-pulmonary  win-
dow, measuring about 8×6.5 cm with a line of
cleavage separating it from the vascular struc-
tures. Patchy areas of necrosis were also seen
with no calcification or cavitations (Figure 2).
The differential diagnosis of the mass was
either  lymphoma  or  thymoma.  A  rigid  bron-
choscopy was performed and showed no endo-
bronchial lesions. Left poster-lateral explorato-
ry  thoracostomy  was  performed  through  the
4th intercostal space. The lesion was a highly
vascular mass seen in the anterior and viscer-
al mediastinum and embedded below the arch
of aorta with adhesion to the descending tho-
racic  aorta,  and  completely  encircling  the
hilum of the left lung (Figure 3).
The left pulmonary artery and veins could
not be evaluated or seen at all. The left phrenic
nerve  was  involved  completely  inside  the
lesion and also the upper part of the pericardi-
um. Enlarged lymph nodes were seen at the
apex of the parietal pleura, medial to the sub-
clavian artery. Frozen sections from two lymph
nodes and from the lesion were examined but
no diagnostic conclusion was made. The peri-
cardium was opened to evaluate the pulmonary
artery and veins and to gain access and con-
trol. The lesion was dissected from the hilum
of the left lung and then from the arch and
descending  aorta.  All  the  pericardial  tissue
involved  in  the  tumor  along  with  the  left
phrenic  nerve  was  excised.  The  left  thymus
gland  pedicle  was  ligated  and  transected.
Diaphragmatic plication was performed to cor-
rect the left diaphragmatic paralysis. 
Macroscopically,  the  lesion  was  a  single
large highly vascular soft tissue mass, grayish-
brown in color, measuring 10×12×5 cm, and
weighing  175  grams.  Upon  sectioning,  it
showed a white gelatinous cut surface with a
smooth  cystic  space.  Microscopically  (Figure
4), the lesion showed proliferation of lymphoid
follicles with hyalinized vessels in the center
of the follicles along with concentric layering
of  lymphocytes  in  the  periphery  (onion-like
appearance).  Marked  vascular  proliferation
was  seen  in  the  interfollicular  regions.  No
atypical  lymphoid  cells  were  identified.
Immunohistochemically, the lesion was highly
positive for CD20, CD3 and CD5. These charac-
teristics were consistent with a diagnosis of
hyaline-vascular  type  Castleman’s  disease.
Because of the infiltrative nature of the mass
and the involvement of the pericardium, the
patient  completed  6  cycles  of  chemotherapy
(CHOP-R) and the follow up CT showed com-
plete resolution of the disease.
Discussion
Castleman’s disease (CD) is a rare and usu-
ally  benign  lymphoproliferative  disorder  of
unknown etiology and is also known as: angio-
follicular hyperplasia, giant lymph node hyper-
plasia,  localized  nodal  hyperplasia,  benign
giant lymphoma, and lymphoid hamartoma.
1 It
was first reported in 1956 by Castleman et al.
2
As  reported,  the  affected  age  group  ranges
from adolescence into the seventh decade, and
it can be solitary or multicentric.
3 About 70% of
CD occurred in the thorax, 10-15% in the neck,
and 10-15% in the abdomen, retroperitoneum,
and pelvis.
4 Histologically, three forms of the
disease have been described; the hyaline-vas-
cular type usually found in the mediastinum
(about  90%  of  cases),  the  plasma  cell  type
which involves extra-thoracic sites
5 and a rare
mixed  type.
5 Clinically,  CD  can  present  as
benign localized resectable disease as in our
case,  or  an  aggressive  multicentric  variant
associated with systemic symptoms and recur-
rence despite treatment. Castleman’s lesions
are typically isointense on T1- and T2-weight-
ed  images  on  MRI  and  homogenously
enhanced  after  contrast.
6 Of  the  localized
forms of CD, the HV type (85% of cases) is
often asymptomatic, whereas the PC type (15%
of cases) has more aggressive clinical course
with  constitutional  symptoms  and  laboratory
abnormalities including anemia, a raised ESR,
polyclonal  gammaglobinemia,  hypoalbumine-
mia, bone marrow plasmacytosis, and throm-
bocytosis.
7 Uncommonly,  a  mixed  type  also
exists.  The  most  common  location  for  this
lesion is in the chest, although it can be seen
in the pelvis, retroperitonium, axilla, or in the
neck .
7 Most of the patients are asymptomatic
and the lesions are accidentally found on chest
X-ray as a rounded mediastinal or hilar mass,
often mistaken for thymoma or bronchial car-
cinoma.
7 It  is  challenging  in  the  context  of
blunt  chest  trauma  management  as  in  our
case. On CT scan, there are three different pat-
terns of the mediastinal lesions of the HV type:
a solitary, non-invasive mass, a dominant infil-
trative mass with associated lymphadenopathy
as in our case, or lymphadenopathy without a
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dominant mass which is often seen with the
PC type.
8,9 The curative treatment of the local-
ized CD is surgical resection, although recur-
rence  can  occur  with  subtotal  resection.
7
Owing to the vascular nature of the disease,
surgery is often complicated by excessive blood
loss which could be minimized using pre-oper-
ative embolization, a facility that we lack in
our hospital. It is recommended to screen for
malignancies in patients with CD to exclude
malignant lymphoma or Kaposi sarcoma that
can occur as long-term complications of the
disease.
9 The multicentric CD (MCD) affects
older  people  (median  age  of  onset  is  55.5
years,  range  19-85  years)  and  slightly  more
often  in  males  than  females  (1.4:1).
7 The
underlying pathogenic mechanism in all cases
of MCD was found to be deregulation of IL-6.
7
Patients usually present with systemic symp-
toms and multiple peripheral lymphoma. Other
manifestations  include,  hepatosplenomegaly,
skin  rash,  rheumatological  symptoms,  renal
failure  and  neurological  involvement
(seizures, peripheral neuropathy).
7 The labo-
ratory abnormalities are similar to the local-
ized PC type. In contrast to the unicentric vari-
ant, surgical resection is not enough and post-
operative  immunosuppressive  therapy  and
radiation is a must.
4
In conclusion, Castleman’s disease is a rare
entity that requires a high index of suspicion,
especially in the context of blunt chest trauma
management. The surgical approach is cura-
tive in the majority of the cases. Therefore, it
should be on the list of the differential diagno-
sis of any mediastinal mass or lymphadenopa-
thy even in trauma cases.
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CaseReport
Figure 1. Frontal chest radiograph demon-
strating evidence of old trauma on the right
side. A near total opacity on the left side
with fluid raising to the axilla. There is evi-
dence of an underlying mass
Figure 3. The mass lying in the visceral
mediastinum,  starting  from  the  aortic
arch to the left pulmonary hilum
Figure  4.  Microscopically,  the  lesion
showed proliferation of lymphoid follicles
with hyalinized vessels in the center of the
follicles along with concentric layering of
lymphocytes in the periphery (Onion-like
appearance).  Marked  vascular  prolifera-
tion  was  seen  in  the  interfollicular
regions. No atypical lymphoid cells were
identified.  Immunohistochemically,  the
lesion was highly positive for CD20 (A)
and CD5 (B).
Figure 2. contrast axial computed tomog-
raphy scan showing A: soft tissue, and B:
coronal  reformations.  There  is  a  large
homogeneous  left  visceral  mediastinal
mass
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